Glenmark Pharma gets conditional USFDA nod for generic Regadenoson injection Kumar Jeetendra | January 21, 2022 Glenmark Pharmaceuticals on Monday said its US arm has received tentative approval from the country’s health regulator for its generic Regadenoson injection. Regadenoson injection is given during the preparation for a radiologic examination of blood flow through the heart to test for coronary artery disease. According to a statement, the tentative approval was granted by …
